The Mitochondrial-Derived Peptide MOTS-c Alleviates Radiation Pneumonitis via an Nrf2-Dependent Mechanism

Radiation pneumonitis is a serious complication for patients undergoing radiation therapy, and effective preventive treatments are urgently needed. This study by Zhang, Huang, Zhang, and colleagues, published in Antioxidants, investigated whether MOTS-c could protect lung tissue from radiation-induced damage.

The researchers used models of radiation-induced lung injury to test MOTS-c's protective effects. They specifically examined whether the peptide's benefits were mediated through the Nrf2 pathway, a master regulator of the cellular antioxidant response that MOTS-c is known to activate.

The results demonstrated that MOTS-c significantly alleviated radiation pneumonitis through an Nrf2-dependent mechanism. The peptide reduced oxidative stress, decreased inflammatory markers, and preserved lung tissue integrity following radiation exposure. When Nrf2 signaling was blocked, MOTS-c's protective effects were diminished, confirming the pathway's central role.

This study adds tissue protection to MOTS-c's growing list of documented benefits. The demonstration that the peptide can protect vital organs from oxidative damage through Nrf2 activation has implications far beyond radiation medicine. It suggests that MOTS-c supplementation could offer broad antioxidant and tissue-protective benefits, complementing its well-established metabolic effects and making it an even more compelling therapeutic peptide.